Nisha Pandey

Experimental Gene-Editing Trial In China Under Scrutiny After 6-Year-Old Dies: Here's What Happened

A six-year-old girl in China died after receiving an experimental gene-editing treatment for a rare neurodevelopmental disorder. The incident sparked scrutiny on ethics and safety of cutting-edge gene therapies, particularly when they involve children and individualized treatments.

The case, uncovered through a joint investigation by Science and Retraction Watch, sparked international concern as the child's death was never disclosed publicly, despite related preclinical research later being published in Nature.

According to the investigation, the six-year-old girl, identified by the pseudonym "Mei," had Snijders Blok-Campeau syndrome, a rare genetic condition. It caused symptoms like mild intellectual disability and developmental delays. 

Her parents reportedly paid more than $800,000 to support development of a personalized ("n=1") <a href="https://www.healthandme.com/health-news/10000-brain-scans-reveal-why-memory-declines-with-age-challenging-long-held-theory-article-155135705" data-type="tilCustomLink">gene-editing therapy</a> designed specifically for their daughter's mutation.

In March 2025, she received a spinal infusion containing trillions of adeno-associated viruses (AAVs) carrying a CRISPR-based gene editor intended to correct the faulty gene in brain cells. Within days, she developed a severe immune reaction and died approximately one week after treatment. 

An internal hospital review concluded that the most likely cause of death was an overwhelming immune response triggered by the viral delivery system rather than the gene-editing mechanism itself.

The controversy extends well beyond the patient's death. According to Science investigation:

<ul><li>The child's death was not publicly disclosed. </li><li>The child's treatment was omitted from a later Nature publication describing related preclinical work.</li><li>Animal studies had reportedly shown warning signs, including severe liver and kidney toxicity at high doses.</li><li>The girl's parents may not have been fully informed about the potential side effects of the therapy. </li></ul>

Following the investigation, local Chinese health authorities reportedly fined the hospital involved for faulty execution of the clinical research. Several experts have called for an independent review of the published research and greater transparency around experimental human gene-editing trials.

Also read: <a href="https://www.healthandme.com/health-news/ebola-outbreak-in-dr-congo-nears-3000-cases-1300-deaths-as-un-warns-virus-is-spreading-like-wildfire-article-155180201" data-type="tilCustomLink">Ebola Outbreak in DR Congo Nears 3,000 Cases, 1,300 Deaths as UN Warns Virus Is 'Spreading Like Wildfire'</a>

Bioethicists and gene therapy researchers say the case underscores the need for complete transparency whenever <a href="https://www.healthandme.com/health-news/ebola-outbreak-in-dr-congo-nears-3000-cases-1300-deaths-as-un-warns-virus-is-spreading-like-wildfire-article-155180201" data-type="tilCustomLink">experimental therapies</a> are tested on humans.

Hank Greely, director of the Center for Law and the Biosciences at Stanford University, told Science that the trial "shouldn't have gone to trial".

Pediatrician Marcelo Bellusci, who participates in gene therapy trials, told El País, "In this type of trial there can be serious side effects, but families are always informed about them. This team skipped the current rules."

Omicron RF.5 Explained: Is the New COVID Variant More Dangerous? | COVID-19 India

Gene-editing technologies such as CRISPR offer the possibility of correcting genetic mutations caused by diseases instead of simply treating symptoms. Several CRISPR-based therapies have shown remarkable success in inherited blood disorders, including <a href="https://www.healthandme.com/health-news/sjgrens-disease-day-new-blood-test-may-detect-the-autoimmune-condition-14-years-before-symptoms-appear-article-155157930" data-type="tilCustomLink">sickle cell disease</a>.

However, experts stress that therapies targeting the brain remain considerably more complex because they often require large viral doses and carry greater risks of immune complications.

As more individualized gene-editing therapies move toward human testing, experts argue that every serious adverse event must be reported promptly to regulators, journals, clinicians, and patients to ensure future treatments become both safer and more trustworthy.

Health Conditions A-Z

health

experimental-gene-editing-trial-in-china-under-scrutiny-after-6-year-old-dies-heres-what-happened

gene editing therapy china

el pas

stanford university

science and retraction watch

center for law and the biosciences

nature

gene editing trial

water-or-electrolytes-biggest-hydration-mistakes-first-time-hyrox-athletes-make

Water Or Electrolytes? Biggest Hydration Mistakes First-Time HYROX Athletes Make

mongolia-confirms-first-human-case-of-bubonic-plague-why-does-the-black-death-keep-lurking-here

Mongolia Confirms First Human Case Of Bubonic Plague; Why Does The Black Death Keep Lurking In This Country?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

A six-year-old girl in China died after receiving an experimental gene-editing treatment for a rare neurodevelopmental disorder. The incident sparked scrutiny on ethics and safety of cutting-edge gene therapies, particularly when they involve children and individualized treatments.The case, uncovered through a joint investigation by Science and Retraction Watch, sparked international concern as the child's death was never disclosed publicly, despite related preclinical research later being published in Nature.What Happened?According to the investigation, the six-year-old girl, identified by the pseudonym "Mei," had Snijders Blok-Campeau syndrome, a rare genetic condition. It caused symptoms like mild intellectual disability and developmental delays. Her parents reportedly paid more than $800,000 to support development of a personalized ("n=1") gene-editing therapy designed specifically for their daughter's mutation. In March 2025, she received a spinal infusion containing trillions of adeno-associated viruses (AAVs) carrying a CRISPR-based gene editor intended to correct the faulty gene in brain cells. Within days, she developed a severe immune reaction and died approximately one week after treatment. An internal hospital review concluded that the most likely cause of death was an overwhelming immune response triggered by the viral delivery system rather than the gene-editing mechanism itself.The controversy extends well beyond the patient's death. According to Science investigation:The child's death was not publicly disclosed. The child's treatment was omitted from a later Nature publication describing related preclinical work.Animal studies had reportedly shown warning signs, including severe liver and kidney toxicity at high doses.The girl's parents may not have been fully informed about the potential side effects of the therapy. Following the investigation, local Chinese health authorities reportedly fined the hospital involved for faulty execution of the clinical research. Several experts have called for an independent review of the published research and greater transparency around experimental human gene-editing trials.Also read: Ebola Outbreak in DR Congo Nears 3,000 Cases, 1,300 Deaths as UN Warns Virus Is 'Spreading Like Wildfire' Bioethicists and gene therapy researchers say the case underscores the need for complete transparency whenever experimental therapies are tested on humans.Hank Greely, director of the Center for Law and the Biosciences at Stanford University, told Science that the trial "shouldn't have gone to trial".Pediatrician Marcelo Bellusci, who participates in gene therapy trials, told El País, "In this type of trial there can be serious side effects, but families are always informed about them. This team skipped the current rules."About Gene-Editing Therapies         Gene-editing technologies such as CRISPR offer the possibility of correcting genetic mutations caused by diseases instead of simply treating symptoms. Several CRISPR-based therapies have shown remarkable success in inherited blood disorders, including sickle cell disease. However, experts stress that therapies targeting the brain remain considerably more complex because they often require large viral doses and carry greater risks of immune complications.As more individualized gene-editing therapies move toward human testing, experts argue that every serious adverse event must be reported promptly to regulators, journals, clinicians, and patients to ensure future treatments become both safer and more trustworthy.

experimental gene-editing trial in china under scrutiny after 6-year-old dies: here's what happened

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Experimental Gene-Editing Trial In China Under Scrutiny After 6-Year-Old Dies: Here's What Happened

Mongolia Confirms First Human Case Of Bubonic Plague; Why Does The Black Death Keep Lurking In This Country?

Ebola Outbreak in DR Congo Nears 3,000 Cases, 1,300 Deaths as UN Warns Virus Is 'Spreading Like Wildfire'

US Man Says ChatGPT's Medical Advice Nearly Killed Him: How Safe Is AI for Health Questions?

Health Conditions A-Z

Experimental Gene-Editing Trial In China Under Scrutiny After 6-Year-Old Dies: Here's What Happened

Water Or Electrolytes? Biggest Hydration Mistakes First-Time HYROX Athletes Make

Mongolia Confirms First Human Case Of Bubonic Plague; Why Does The Black Death Keep Lurking In This Country?